Webinars offer a variety of presentations from worldwide experts in the field of Biosimilars.

Biosimilars in Nephrology

Jay Wish, MDJay Wish, MD
Professor of Clinical Medicine
Indiana University
Indianapolis, Indiana

Biosimilars on the Horizon in the US: A Review of What’s Coming and the European Experience

James G. Stevenson, PharmD, FASHPJames G. Stevenson, PharmD, FASHP
University of Michigan College of Pharmacy
Visante, Inc.
Ann Arbor, Michigan

Biosimilars: Payer and Formulary Considerations

Ross M. Miller, MD, MPH, FACPERoss M. Miller, MD, MPH, FACPE
Medical Advisor
California Department of Health Care Services
Los Angeles, California

Clinician and Payer Perspectives on the First Biosimilar Approved in the US


Gary H. Lyman, MD, MPHGary H. Lyman, MD, MPH
Hutchinson Institute for Cancer Outcomes Research
Professor of Medicine
University of Washington


Edmund J. Pezalla, MD, MPHEdmund J. Pezalla, MD, MPH
Vice President
Pharmaceutical Policy and Strategy
Hartford, Connecticut

Comprehensive Review of Biosimilars vs. Reference Biologics

jonathan kayJonathan Kay, MD
Director of Clinical Research
Rheumatology Division
UMASS Memorial Medical Center
Professor of Medicine
University of Massachusetts Medical School
Worcester, Massachusetts

Interview: Expert Perspective on Biosimilars

Sanjiv S. Agarwala, MDSanjiv S. Agarwala, MD
Chief, Oncology & Hematology
St. Luke’s University Health Network
Professor of Medicine
Temple University
Philadelphia, Pennsylvania

The Fundamentals of Biosimilar Regulation and Development in the US

edward  liEdward Li, PharmD, MPH, BCOP
Associate Professor
University of New England College of Pharmacy
Portland, Maine

New & Noteworthy